Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
- 4 November 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neuropsychopharmacology
- Vol. 35 (2), 581-590
- https://doi.org/10.1038/npp.2009.164
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Does switching to a new antipsychotic improve outcomes?: Data from the CATIE TrialSchizophrenia Research, 2009
- Limitations of current therapies: Why do patients switch therapies?European Neuropsychopharmacology, 2008
- Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1Schizophrenia Research, 2008
- Assessment of strategies for switching patients from olanzapine to risperidone: A randomized, open-label, rater-blinded studyBMC Medicine, 2008
- Predicting antipsychotic drug response – Replication and extension to six weeks in an international olanzapine studySchizophrenia Research, 2008
- Switching from risperidone to olanzapine in a one-year, randomized, open-label effectiveness study of schizophreniaCurrent Medical Research and Opinion, 2008
- Clinical, Functional, and Economic Ramifications of Early Nonresponse to Antipsychotics in the Naturalistic Treatment of SchizophreniaSchizophrenia Bulletin, 2007
- A Randomized, 1-Year Follow-up Study of Olanzapine and Risperidone in the Treatment of Negative Symptoms in Outpatients with SchizophreniaJournal of Clinical Psychopharmacology, 2006
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970